Theratechnologies Inc. (TSE:TH - Get Free Report) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$2.15 and traded as high as C$2.47. Theratechnologies shares last traded at C$2.46, with a volume of 33,073 shares traded.
Theratechnologies Stock Performance
The firm's 50-day simple moving average is C$2.16 and its two-hundred day simple moving average is C$1.94. The company has a current ratio of 1.10, a quick ratio of 0.64 and a debt-to-equity ratio of 562.07. The stock has a market capitalization of C$118.63 million, a PE ratio of -14.33, a PEG ratio of -8.50 and a beta of 1.73.
About Theratechnologies
(
Get Free Report)
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
Further Reading
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.